Teva Pharmaceutical Industries Ltd.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $36.80B | $47.06B | $2.18B |
| Jun 2022 | $36.12B | $45.93B | $2.06B |
| Sep 2022 | $34.75B | $44.25B | $2.23B |
| Dec 2022 | $35.41B | $44.01B | $2.80B |
| Mar 2023 | $34.96B | $43.46B | $2.14B |
| Jun 2023 | $35.51B | $43.10B | $2.67B |
| Sep 2023 | $34.71B | $42.10B | $2.25B |
| Dec 2023 | $35.35B | $43.48B | $3.23B |
| Mar 2024 | $35.23B | $42.77B | $2.99B |
| Jun 2024 | $34.77B | $41.34B | $2.26B |
| Sep 2024 | $35.38B | $41.76B | $3.32B |
| Dec 2024 | $33.61B | $39.33B | $3.30B |
| Mar 2025 | $32.15B | $38.42B | $1.70B |
| Jun 2025 | $33.30B | $40.13B | $2.16B |
| Sep 2025 | $32.60B | $39.86B | $2.20B |
| Dec 2025 | $32.83B | $40.75B | $3.56B |
| Mar 2026 | $31.81B | $40.04B | $3.74B |
| Jun 2026 | $32.10B | $39.86B | $3.66B |